June 2018—Beckman Coulter Diagnostics launched its Access Sensitive Estradiol in the U.S. and in the majority of worldwide markets. The assay aims to help laboratories deliver more accurate results for patients seeking answers to reproductive health questions. It has a broad measuring range, surpassing clinical decision limits for in vitro fertilization hyper responders. This may allow laboratories to report accurate patient results while avoiding costly dilutions of samples from patients undergoing IVF. The Access Sensitive Estradiol is the only assay in the market with published pediatric reference ranges, according to a press release from the company. It is for use on the company’s immunoassay systems, including the Access 2, DxI 600, and DxI 800.
Beckman Coulter Diagnostics, 714-993-5321